LPL c.429+20A>T

Variant ID: 8-19809479-A-T

NM_000237.2(LPL):c.429+20A>T

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Application of proprotein convertase subtilisin/kexin type 9 inhibitor, evolocumab, in patients with severe hypertriglyceridemia.

Chinese Medical Journal
Peng, Yanren Y; Guo, Danxia D; Jiang, Sijie S; Zheng, Hua H
Publication Date: 2022-03-20

Variant appearance in text: rs3735959
PubMed Link: 34924503
Variant Present in the following documents:
  • Main text
  • cm9-135-730.pdf
View BVdb publication page